Saakshi Medtech Peer Comparison

NSE: SAAKSHI

₹365.00

₹1.00 (0.27%)

As on 08-Oct-2026IST

Market cap

₹718 Cr

Revenue (TTM)

₹92 Cr

P/E Ratio

58.4

P/B Ratio

7.2

Div. Yield

0 %

Edit

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Market cap (₹ Cr)	718	16,231	1,530	372	316
Revenue (₹ Cr)	92	1,997	342	183	153
Net Profit (₹ Cr)	4.71	307.01	55.72	12.72	4.34
Net Margin (%)	5.06	14.56	16.04	6.90	2.70
RoE (%)	4.92	10.63	25.55	10.39	2.29
Price to Earnings	58.42	51.51	27.45	34.20	72.77
Price-To-Book	7.17	5.10	6.04	--	1.72

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Operating Revenue	92.43	1,669.83	313.14	--	109.66
Total Income	93.00	1,758.96	325.22	--	122.37
Total Expenditure	82.12	1,214.12	251.50	--	117.47
EBITDA	10.31	455.71	61.64	--	-7.81
Depreciation	3.89	83.18	7.03	--	2.34
EBIT	6.42	372.53	54.61	--	-10.15
Interest	0.41	14.32	14.97	--	1.21
Other Income	0.57	89.13	12.08	--	12.71
Exceptional Items	--	--	-16.97	--	--
Profit before Tax	6.59	452.52	34.74	--	1.34
Provision for Tax	1.88	113.96	19.06	--	0.50
Profit after Tax	4.71	338.56	15.68	--	0.85

Liabilities (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Shareholder's Funds	98.04	2,765.66	189.95	--	194.29
Minority Interest	--	--	--	--	--
Non-Current Liabilities	14.44	56.40	85.42	--	-0.18
Current Liabilities	18.62	457.71	179.14	--	12.40
Total Liabilities	131.33	3,279.77	455.50	--	209.98

Assets (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Non-Current Assets	76.67	1,269.89	189.88	--	16.55
Current Assets	54.44	2,009.87	264.64	--	189.95
Total Assets	131.33	3,279.77	455.50	--	209.98
Total Debt*	17.82	177.65	166.29	--	2.37
Net Current Assets	35.81	1,552.17	85.50	--	177.55
Contingent Liabilities	5.29	77.12	19.30	--	0.02

Cashflow (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Cash From Operating Activities	3.02	233.05	17.21	--	-19.08
Cash Flow from Investing Activities	-14.74	-1,187.18	-77.47	--	8.44
Cash from Financing Activities	-0.60	950.51	53.18	--	-0.17
Net Cash Inflow / Outflow	-12.32	-3.63	-7.08	--	-10.81

Ratios

Profitability Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
ROCE (%)	6.16	20.37	16.17	--	1.31
ROE (%)	4.92	16.01	8.92	--	0.44
ROA (%)	3.60	12.99	3.95	--	0.42
EBIT Margin (%)	11.77	32.63	23.54	--	4.46
Net Margin (%)	5.06	19.25	4.82	--	0.69
Cash Profit Margin (%)	7.98	25.15	7.25	--	2.61

Growth Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Revenue Growth (%)	-24.14	21.37	53.77	--	19.29
EBIT Growth (%)	-46.94	30.11	80.39	--	1,494.46
Net Profit Growth (%)	-58.34	31.09	-27.54	--	147.16
EPS Growth (%)	-58.34	24.16	-44.23	--	147.16
Book Value Growth (%)	5.05	88.41	17.39	--	0.61

Valuation Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Price / Earnings	48.10	67.10	0.00	--	248.64
Price / Book Value	2.31	8.22	0.00	--	1.08
Dividend Yield (%)	0.00	0.16	--	--	0.00
EV/EBITDA	22.15	41.75	1.64	--	17.43
Market Cap (₹ Cr)	226.53	22,718.23	0.00	--	210.35

Solvency Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Debt to Equity	0.18	0.06	0.88	--	0.01
Short term debt to equity ratio	0.00	0.06	0.29	--	0.00
Current Ratio	2.92	4.39	1.48	--	15.32
Quick Ratio	1.83	3.77	0.97	--	12.10
Interest Coverage	17.26	32.59	3.32	--	2.11

Operating Efficiency Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Debtors to sales (%)	23.68	20.94	26.38	--	3.03
Asset Turnover	0.82	0.64	0.79	--	0.60
Receivable days	66.41	67.43	63.55	--	7.39
Inventory Days	71.27	55.13	113.91	--	105.87
Payable days	54.28	74.14	143.30	--	31.48
Cash Conversion Cycle	83.40	48.42	34.16	--	81.78

Annual
Quarterly